Zhu, Frank http://orcid.org/0000-0003-0644-3876
Ang, Jocelyn Y.
Article History
Accepted: 14 March 2022
First Online: 11 April 2022
Compliance with Ethical Standards
:
: Dr. Frank Zhu declares that he has no conflict of interest. Dr. Jocelyn Ang has participated as a site principal investigator for Eli Lilly and Company Study: J2W-MC PYAB/Addendum 2 (pediatric COVID-19 Study addendum), Eli Lilly and Company's Baricitinib Pediatric COVID-19 Study, from F. Hoffmann-La Roche Ltd 's Tocilizumab Pediatric COVID-19 Study, Regeneron Pharmaceuticals, Inc. 's SARS CoV2 Monoclonal Antibodies Pediatric COVID-19 Study and site co-investigator for Gilead's Remdesivir Pediatric COVID-19 study. Her employer received institutional funds associated with these research projects.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.